The field of clinical endocrinology and rare disorders encompasses a diverse range of hormonal conditions beyond common metabolic diseases. Disorders such as Addison’s disease, Cushing’s syndrome, and congenital adrenal hyperplasia require specialized diagnostic and therapeutic approaches. Advances in molecular endocrinology have improved the understanding of genetic mutations and their role in rare endocrine dysfunctions. Precision medicine, including targeted hormone replacement therapies and gene-based interventions, is transforming treatment strategies. Improved diagnostic tools, including next-generation sequencing and biomarker analysis, are enabling earlier detection and better disease management. Continued research and interdisciplinary collaboration are crucial to developing innovative therapies for rare endocrine disorders.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti